Literature DB >> 10730730

Advancement of the mandible facilitates nasal breathing in human subjects sedated with midazolam.

Y Kawauchi1, T Oshima, S Suzuki, Y Saitoh, H Toyooka.   

Abstract

PURPOSE: To determine how anterior advancement of the mandible (ADM) affects spontaneous breathing through the nasal route in healthy human volunteers sedated with intravenous midazolam.
METHODS: In four subjects who exhibited nasal breathing during midazolam sedation (intravenous dose: 0.09+/-0.02 mg x kg(-1), mean +/- SD), we measured respiratory rate (RR), peak nasal inspiratory airflow rate (V(nIpeak)) peak nasal expiratory airflow rate (V(nEpeak), duty ratio (Ti/Ttot) and nasal resistance (Rn) before and after ADM. Nasal resistance was calculated by dividing the difference between nasal mask and oropharyngeal pressure by airflow rate at peak nasal inspiratory airflow.
RESULTS: The RR, V(nIpeak), and V(nEpeak) increased following ADM (P<0.001, respectively). On the contrary, Ti/Ttot decreased after ADM (P<0.001). Consequently, ADM decreased Rn from 30.4+/-40.8 to 5.0+/-5.6 (cm H2O x l(-1) x sec(-1)) (mean +/- SD) (P<0.001). In these four subjects, no respiratory airflow was observed through the oral route before and after ADM.
CONCLUSION: Advancement of the mandible decreases nasal resistance, thereby facilitating spontaneous breathing through the nasal route in normal humans sedated with midazolam.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10730730     DOI: 10.1007/BF03018915

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  2 in total

1.  An unusual case of hypnic headache ameliorated utilizing a mandibular advancement oral appliance.

Authors:  Steven D Bender
Journal:  Sleep Breath       Date:  2011-07-29       Impact factor: 2.816

2.  Mandibular advancement impairs swallowing ability more than head extension but less than mouth opening in the supine position.

Authors:  Hiroshi Hanamoto; Eriko Togawa; Hiroharu Maegawa; Chizuko Yokoe; Mika Inoue; Aiko Oyamaguchi; Chiho Kudo; Hitoshi Niwa
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.